In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway

Pharmaceutical agents for halting the progression of Parkinson’s disease (PD) are lacking. The current available medications only relieve clinical symptoms and may cause severe side effects. Therefore, there is an urgent need for novel drug candidates for PD. In this study, we demonstrated the neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Chien-Wei, Chen, Nan-Fu, Wen, Zhi-Hong, Yang, Wen-Ya, Kuo, Hsiao-Mei, Sung, Ping-Jyun, Su, Jui-Hsin, Cheng, Shu-Yu, Chen, Wu-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627894/
https://www.ncbi.nlm.nih.gov/pubmed/31146323
http://dx.doi.org/10.3390/md17060315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627894/
https://www.ncbi.nlm.nih.gov/pubmed/31146323
http://dx.doi.org/10.3390/md17060315

Ejemplares similares